A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease

Area of Science:

• Rheumatology
• Pulmonology
• Pathology

Background:

• Pulmonary involvement is frequent and severe in mixed connective tissue disease (MCTD), often presenting subtly.
• Treatment response to corticosteroids and cyclophosphamide is variable, necessitating careful patient monitoring.

Observation:

• Serial pulmonary function tests, particularly diffusing capacity, are crucial for detecting deterioration.
• Overlap with systemic sclerosis and nailfold capillary microscopy findings may predict severe pulmonary complications.
• Pulmonary hypertension is a significant concern, and its prediction is challenging using standard clinical or diagnostic tools.

Findings:

• The primary pathological finding in MCTD-associated pulmonary hypertension is intimal proliferation and medial hypertrophy of pulmonary arterioles.
• Pulmonary interstitial abnormalities are minimal, indicating vascular lesions are key to pulmonary hypertension in MCTD.
• While some cases progress rapidly, many MCTD patients experience significant improvement in disabling pulmonary dysfunction with steroid and/or cyclophosphamide therapy, with 38% achieving remission.

Implications:

• Regular pulmonary monitoring is essential for early detection of complications in MCTD patients.
• Identifying patients at risk for severe pulmonary involvement, possibly through capillary microscopy, can inform proactive management strategies.
• Understanding the vascular pathology is critical for developing targeted therapies for pulmonary hypertension in MCTD.